 Profile
A fellow of the Australian Institute of Company Directors, Mr. Michael Milne possesses over 25 years of experience sitting on public and private management boards. As Director of Life Therapeutics Limited, Mr. Milne puts all of his experience to use in making sure the company stays focused on improving the health and lives of its global clients by providing the most innovative products and specially designed technology of any biotechnology company in the world.
Spearheading the effort to keep Life Therapeutics Limited from bankruptcy, Mr. Michael Milne was instrumental in reviving the company’s business plan and preventing the dissolution of over 400 American jobs. The company consists of two separate divisions, Life Sera and Life Diagnostics, and specializes in offering the complete cycle of plasma-derived products. Thanks to Mr. Milne’s steady leadership, Life Therapeutics Ltd. is more prepared now than ever before to provide the highest quality plasma products, donor management solutions, and diagnostic offerings possible.
Outside of his continued management of Life Therapeutics Limited, Mr. Michael Milne also has the unique distinction of being the Baron of Corstorphine. Corstorphine, a suburb of Edinburgh, Scotland, has maintained a Barony since 1431, and Mr. Michael Milne is its 34th official Baron. Passing into Mr. Milne’s possession in 2005 from The Corstorphine Trust, the Barony continues primarily for charitable and historical reasons and represents no official feudal title.
A resident of Sydney, Australia, Mr. Michael Milne is an enthusiastic sailor and a member of the Royal Sydney Yacht Squadron.
|
|
